Skip to main content
. 2025 Aug 12;12:1587960. doi: 10.3389/fmed.2025.1587960

Table 1.

Laboratory data at the onset of mixed-type AIHA.

Laboratory parameters Results Reference range
ANA profile Negative Negative
Albumin, g/L 33.5 40.0–55.0
ALT, U/L 27 7–40
ANCA Negative Negative
APTT, sec 35.4 28.0–43.5
AFP, ng/ml 1.62 ≤7
ASO, IU/ml 459.0 0–408
AST, U/L 34 13–35
BUN, mmol/L 6.52 3.1–8.8
CRP, mg/L 11.70 0.00–8.00
CEA, ng/ml 1.32 ≤5
Creatinine, μmol/L 44 41–81
D-dimer, μg/ml 1.43 0–0.50
Direct Antiglobulin Test Positive Negative
Folate, ng/mL 7.09 4.20–19.8
Fibrinogen, g/L 3.70 2.00–4.00
Hemoglobin, g/L 61 115–150
Hematocrit,% 16.4 35.0–45.0
INR, ratio 1.11 0.80–1.20
LDH, U/L 347 120–250
PT, sec 14.4 11.0–15.0
Red blood cell, 1012/L 1.97 3.80–5.10
Reticulocyte count, 109/L 147.70 36.3–195.7
Reticulocyte percentage, % 7.5 0.5–1.5
Serum Iron, μmol/L 13.9 7.8–32.2
TP, g/L 74.3 65.0–85.0
Total bilirubin, μmol/L 28.6 0–21
Unconjugated bilirubin, μmol/L 22.4 0–17
Vitamin B12, pg./ml 360.00 197–771
White blood cell, 109/L 9.48 3.5--9.5

TP = total protein; LDH = lactate dehydrogenase; ASO = Anti-Streptolysin O; INR = international normalized ratio; APTT = activated partial thromboplastin time; PT = Prothrombin Time; AFP = Alpha-fetoprotein; CEA = carcinoembryonic antigen; ANCA = anti-neutrophil cytoplasmic antibody.